What is Surrozen Inc (SRZN) stock price today?

Surrozen Inc (SRZN) currently trades at $31.56 per share. The stock has a market capitalization of $371.23M and a P/E ratio of —x.

Is SRZN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Surrozen Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -10.25.

What is Surrozen Inc's revenue and earnings?

Surrozen Inc has trailing twelve-month (TTM) revenue of $3.48M with profit margins of 0.00%. Earnings per share (EPS) is $-32.37.

Is Surrozen Inc financially healthy?

Surrozen Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -10.25 places it in the distress.

SRZN

Surrozen Inc

NASDAQ: SRZN · HEALTHCARE · BIOTECHNOLOGY

$31.56

+1.87% today

Updated 2026-04-29

Market cap

$371.23M

P/E ratio

—

P/S ratio

106.77x

EPS (TTM)

$-32.37

Dividend yield

—

52W range

$6 – $34

Volume

0.1M

Market cap

$371.23M

P/E ratio

—

P/S ratio

106.77x

EPS (TTM)

$-32.37

Dividend yield

—

52W range

$6 – $34

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

6.0

Quality

2.5

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-10.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$38.75

+22.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity -0.30x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -10.25 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.87M

- Revenue declining -19.40% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$12.50M	$12.50M	$10.65M	$3.48M	$3.48M
Net income	$-27.67M	$-43.04M	$-63.56M	$-242.03M	$-183.16M
EPS	—	—	—	—	$-32.37
Free cash flow	$-44.87M	$-40.76M	$-17.65M	$-30.37M	$-5.87M
Profit margin	-221.35%	-344.34%	-596.56%	-6,960.77%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SRZN	$371.23M	25	2.7	2.5	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Surrozen Inc trades at $31.56. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -10.25, it sits in the distress. TTM revenue stands at $3.48M.

Frequently asked questions

What is Surrozen Inc's stock price?

Surrozen Inc (SRZN) trades at $31.56.

Is Surrozen Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Surrozen Inc (SRZN)?

The analyst target price is $38.75, representing +22.8% upside from the current price of $31.56.

What is Surrozen Inc's revenue?

TTM revenue is $3.48M.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-10.25 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.surrozen.com

Quick metrics

P/S ratio106.77x

ROE-62.80%

Beta0.52

50D MA$27.97

200D MA$18.43

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SRZN vs LLY →SRZN vs JNJ →SRZN vs ABBV →Stock screener →